Lersivirine: 48-Week Results Compared to Efavirenz in Phase 2 Treatment-Naive Study - The Body
Links shared publicly online about this topic.
- 30total visits
Lersivirine: 48-Week Results Compared to Efavirenz in Phase 2 Treatment-Naive Study - The Body
Lersivirine is a once-daily NNRTI from ViiV that was originally developed by Pfizer and previously called UK-453061 and that is promising due to a ...
View full resource at thebody.com
Tags: HIV, AIDS, HIV Medication, STD, Sustiva, Pfizer
Most Recently Shared on September 1, 2011 at 1:00 pm By:
IAS 2011: Lersivirine: 48-Week Results Compared to Efavirenz in Phase 2 Treatment-Naive Study http://t.co/yidn0PJ #ias2011 #hiv #aids
Advertisement
